AEG's mission is to create
personal and business growth
through trusted relationships.
About AEGAEG integrates capability, capital, connections and community to help businesses grow.
Our Elite AdvisorsAEG advisors are recognized experts in 25 disciplines drawn from top firms in each city.
Our Advisory BoardOur Advisory Board consists of highly regarded CEOs and executives from diverse industries.
Our CEO CommunityAEG has curated a community of owners through educational, social and business development activities.
Our GovCon Affinity GroupAEG’s GovCon Affinity Group members are uniquely able to support both government agencies and GovCon firms.
Know Your Twin Value GapAEG helps owners understand and close both personal and business value gaps.
Grow Your CompanyAEG helps companies understand and tackle individual and complex growth challenges.
Exit On Your TermsAEG helps owners understand and execute successful transitions of their companies.
Build Personal WealthAEG helps owners grow and protect what they created and live a fulfilling life.With cybersecurity talent scarce, companies should consider the unprecedented number of AI-displaced candidates who will soon be entering the job market with skills that can be trained to work in the field. The post For Cyber Talent, Look For Transferable Skills appeared first on ChiefExecutive.net. The rise of generative AI is expected to displace more…
To encourage risk-taking, leaders must create a safe space for experimentation and learning from failure. The post Upskilling Is Investing In Your Team—And There’s No Better Growth Strategy appeared first on ChiefExecutive.net. The employees within our organizations all possess unique skill sets—their varied interests and expertise are why we hired them. These diverse talents are…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…
Hadean Ventures has announced the final close of Hadean Capital II at EUR 144m, substantially above target of EUR 125m. The fund will invest in life science start-up companies across Europewith an emphasis on the Nordics and German-speaking countries. The strategy includes pharma, biotech, medtech, diagnostics and digital health. Hadean Capital II was launched in…